HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests

Antiviral Therapy

Volumn 15, Issue 1, 2010, Pages 121-126

  Monleau, Marjorie ^a   Plantier, Jean Christophe ^b   Peeters, Martine ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; COST BENEFIT ANALYSIS; DRUG RESISTANCE; GENE AMPLIFICATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYLOGENY; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VECTORCARDIOGRAPHY;

ANTIVIRAL AGENTS; BASE SEQUENCE; DNA, VIRAL; DRUG RESISTANCE, VIRAL; EQUIPMENT CONTAMINATION; FALSE POSITIVE REACTIONS; GENETIC VECTORS; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 77949402012     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1478     Document Type: Article

References (12)

1. World Health Organization. Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva: World Health Organization 2008.
2. Rouet F, Rouzioux C. The measurement of HIV-1 viral load in resource-limited settings: how and where? Clin Lab 2007; 53:135-148.
3. Vergne L, Peeters M, Mpoudi-Ngole E, et al. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 2000; 38:3919-3925.
4. Descamps D, Delaugerre C, Masquelier B, et al. Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance. J Med Virol 2006; 78:153-160.
5. Fontaine E, Riva C, Peeters M, et al. Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J. J Acquir Immune Defic Syndr 2001; 28:254-258.
6. Pandit A, Mackay WG, Steel C, van Loon AM, Schuurman R. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme. J Clin Virol 2008; 43:401-406.
7. Monleau M, Montavon C, Laurent C, et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for HIV-1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol 2009; 47:1107-1118.
8. Plantier JC, Dachraoui R, Lemee V, et al. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19:391-397.
9. Fransen K, Zhong P, De Beenhouwer H, et al. Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1994; 8:317-322.
10. Delwart EL, Busch MP, Kalish ML, Mosley JW, Mullins JI. Rapid molecular epidemiology of human immunodeficiency virus transmission. AIDS Res Hum Retroviruses 1995; 11:1081-1093.
11. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-425.
12. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680.